Eastgate Biotech Corp
OTC:ETBI

Watchlist Manager
Eastgate Biotech Corp Logo
Eastgate Biotech Corp
OTC:ETBI
Watchlist
Price: 0.003 USD Market Closed
Market Cap: 6.2m USD

Operating Margin

-4 837.8%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4 837.8%
=
Operating Income
$-6.7m
/
Revenue
$137.6k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4 837.8%
=
Operating Income
$-6.7m
/
Revenue
$137.6k

Peer Comparison

Country Company Market Cap Operating
Margin
US
Eastgate Biotech Corp
OTC:ETBI
6.2m USD
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...
SE
Zinzino AB
STO:ZZ B
4.4B SEK
Loading...
CN
Shanghai Aiyingshi Co Ltd
SSE:603214
2.5B CNY
Loading...
CN
Nanjing Sinolife United Co Ltd
HKEX:3332
663.8m HKD
Loading...
CA
Nova Cannabis Inc
TSX:NOVC
108.6m CAD
Loading...
US
Franchise Group Inc
F:3HC
38.8m EUR
Loading...
JP
Soiken Holdings Inc
TSE:2385
7B JPY
Loading...
HK
Ausupreme International Holdings Ltd
HKEX:2031
251.5m HKD
Loading...
NZ
Comvita Ltd
NZX:CVT
40.2m NZD
Loading...
CA
Optimi Health Corp
CNSX:OPTI
30.4m CAD
Loading...
No Stocks Found

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 14 112 companies
5th percentile
-4 837.8%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Eastgate Biotech Corp
Glance View

Market Cap
6.2m USD
Industry
N/A

Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2014-01-16. The firm produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The company utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The firm develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles).

ETBI Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-4 837.8%
=
Operating Income
$-6.7m
/
Revenue
$137.6k
How has Operating Margin changed over time?

Over the last 2 years, Eastgate Biotech Corp’s Operating Margin has increased from -7 566.7% to -4 837.8%. During this period, it reached a low of -7 566.7% on Jun 30, 2015 and a high of -2 807.7% on Mar 31, 2016.

Back to Top